Results for tag: "Emgality"

Emgality is a class of drugs used to treat neurological disorders, such as migraine, cluster headache, and epilepsy. It is a type of calcitonin gene-related peptide (CGRP) receptor antagonist, which works by blocking the action of CGRP, a molecule involved in the transmission of pain signals. Emgality is used to reduce the frequency and severity of migraine attacks, and to reduce the frequency of cluster headache attacks. It is also used to reduce the frequency of seizures in people with epilepsy. Emgality is a relatively new class of drugs, and is part of a larger market of Central Nervous System (CNS) drugs. This market includes drugs used to treat a variety of neurological disorders, such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and depression. Some companies in the Emgality market include Eli Lilly, Amgen, Teva Pharmaceuticals, and Novartis. Show Less Read more